Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rheumatoid arthritis and cardiovascular disease.

Literature DB >> 18817644

Rheumatoid arthritis and cardiovascular disease.

Abstract

An increased risk of cardiovascular events and subclinical atherosclerosis in patients with rheumatoid arthritis (RA) has been attributed to the inflammatory milieu associated with this chronic autoimmune disease and possibly to the independent effects of RA medications on risk. This review provides an update on the most recent epidemiologic studies documenting this relationship and noteworthy publications examining RA-related factors that could influence the role of traditional cardiovascular risk factors and expression of atherosclerotic disease in patients with RA.

Entities: Disease Species

Mesh：

Year: 2008 PMID： 18817644 DOI： 10.1007/s11926-008-0063-0

Source DB: PubMed Journal: Curr Rheumatol Rep ISSN： 1523-3774 Impact factor: 4.592

60 in total

1. Acceleration of atherosclerosis during the course of rheumatoid arthritis.

Authors: Inmaculada Del Rincón; Daniel H O'Leary; Gregory L Freeman; Agustín Escalante
Journal: Atherosclerosis Date: 2006-11-13 Impact factor: 5.162

2. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.

Authors: Yu Asanuma; Cecilia P Chung; Annette Oeser; Joseph F Solus; Ingrid Avalos; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Tuulikki Sokka; Theodore Pincus; C Michael Stein
Journal: Atherosclerosis Date: 2007-06-14 Impact factor: 5.162

3. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis.

Authors: Ozgur Ciftci; Sema Yilmaz; Semra Topcu; Mustafa Caliskan; Hakan Gullu; Dogan Erdogan; Baris O Pamuk; Aylin Yildirir; Haldun Muderrisoglu
Journal: Atherosclerosis Date: 2007-12-31 Impact factor: 5.162

4. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

Authors: V F Panoulas; K M J Douglas; A Stavropoulos-Kalinoglou; G S Metsios; P Nightingale; M D Kita; M S Elisaf; G D Kitas
Journal: Rheumatology (Oxford) Date: 2008-01 Impact factor: 7.580

5. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.

Authors: Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Ingrid Avalos; Tuulikki Sokka; Paolo Raggi; Theodore Pincus; C Michael Stein
Journal: Arthritis Rheum Date: 2008-07

6. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample.

Authors: Paola De Pablo; Thomas Dietrich; Elizabeth W Karlson
Journal: Arthritis Rheum Date: 2007-08-15

7. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis.

Authors: Giovanni La Montagna; Federico Cacciapuoti; Rosario Buono; Daniela Manzella; Gianna Angela Mennillo; Alessandro Arciello; Gabriele Valentini; Giuseppe Paolisso
Journal: Diab Vasc Dis Res Date: 2007-06 Impact factor: 3.291

8. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.

Authors: Yoshisuke Haruna; Yoshitaka Morita; Toyotaka Yada; Minoru Satoh; David A Fox; Naoki Kashihara
Journal: Arthritis Rheum Date: 2007-06

9. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Authors: Joachim Listing; Anja Strangfeld; Jörn Kekow; Matthias Schneider; Andreas Kapelle; Siegfried Wassenberg; Angela Zink
Journal: Arthritis Rheum Date: 2008-03

10. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.

Authors: S Wållberg-Jonsson; K Caidahl; N Klintland; G Nyberg; S Rantapää-Dahlqvist
Journal: Scand J Rheumatol Date: 2008 Jan-Feb Impact factor: 3.641

7 in total

1. Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.

Authors: Androniki Bili; Lisa L Schroeder; Lindsay J Ledwich; H Lester Kirchner; Eric D Newman; Mary Chester M Wasko
Journal: Rheumatol Int Date: 2010-03-27 Impact factor: 2.631

6. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients.

Authors: Hsin-Hua Chen; Der-Yuan Chen; Chi-Chen Lin; Yi-Ming Chen; Kuo-Lung Lai; Ching-Heng Lin
Journal: Ther Clin Risk Manag Date: 2017-05-02 Impact factor: 2.423

7. Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease.

Authors: Jonida K Cote; Androniki Bili
Journal: ISRN Rheumatol Date: 2013-11-06